4Dcell joined 26 European startups to pitch its SmartHeart cardiac testing platform at the EIC Corporate Day's exclusive corporate partnership event in Brussels.

Learn how human-based models like iPSC-derived cardiomyocytes and 3D organoid systems improve translational outcomes in academic drug discovery.

Cardiac organoids finally solve drug development's costliest problem by predicting human heart responses animal testing missed completely.